Nixxy proposes raising authorized common shares to 500M
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Nixxy, Inc. is seeking stockholder votes on five proposals at a virtual annual meeting on December 23, 2026: elect current director nominees David Kratochvil, Elsa Sung, Simon Paul Kearney, Joe Conlon and Robert Reda; ratify KG CPA LLP as 2026 auditor; expand authorized common shares; amend the 2025 Equity Incentive Plan; and permit adjournment if needed. The board recommends “FOR” each proposal.
Authorized common shares would increase from 10,000,000 to 500,000,000 if approved; future issuances could dilute voting power and ownership percentages. The plan amendment would increase the post-reverse-split share reserve from 125,000 to 250,000, effective at the meeting if approved. The board-approved 1-for-20 reverse split is scheduled to take effect November 20, 2026. Common shares outstanding were 1,477,067 as of November 2, 2026, stated on a post-reverse-split basis. The authorized-share amendment would take effect when a certificate is filed in Nevada, which Nixxy expects promptly after the meeting.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- None.
Negative
- Moderate point. Forward-looking: it has not happened yet and may not happen.Authorized shares would rise from 10,000,000 to 500,000,000 if approved; future issuances could dilute voting power and ownership percentage.
Filing Explained
If approved, the plan's reserve can grow each year through two thousand thirty-five beyond two hundred fifty thousand post-split shares.
This preliminary proxy asks shareholders to approve a 2025 Plan amendment that would add annual share capacity beyond the 250,000-share post-split reserve; the change is proposed, not yet approved.
If approved, the plan would add shares each January 1 from
Approval of the plan and authorized-share proposals requires a majority of voting power present and entitled to vote; abstentions count against, while broker non-votes have no effect.
Key Figures
Key Terms
Authorized Share Increase technical
broker non-vote regulatory
restricted stock units financial
stock appreciation rights financial
beneficial ownership regulatory
Reverse Split technical
Stock Split
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is Nixxy (NIXX) asking stockholders to approve?
How many authorized shares would Nixxy (NIXX) have under Proposal 3?
How many shares would the Nixxy (NIXX) 2025 Plan reserve?
What vote is required for the Nixxy (NIXX) share increase and plan amendment?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(Rule 14a-101)
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment No.)
| Filed by Registrant | ☒ |
| Filed by Party other than Registrant | ☐ |
Check the appropriate box:
| ☒ | Preliminary Proxy Statement | ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement | ☐ | Definitive Additional Materials |
| ☐ | Soliciting Materials Pursuant to §240.14a-12 |
| Nixxy, Inc. |
| (Name of Registrant as Specified In Its Charter) |
| (Name of Person(s) Filing Proxy Statement, if other than the Registrant) |
Payment of Filing Fee (Check the appropriate box):
| ☒ | No fee required. |
| ☐ | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
| (1) | Title of each class of securities to which transaction applies: | |
| (2) | Aggregate number of securities to which transaction applies: | |
| (3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined): | |
| $_____ per share as determined under Rule 0-11 under the Exchange Act. | ||
| (4) | Proposed maximum aggregate value of transaction: | |
| (5) | Total fee paid: |
| ☐ | Fee paid previously with preliminary materials. |
| ☐ | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
| (1) | Amount previously paid: | |
| (2) | Form, Schedule or Registration Statement No.: | |
| (3) | Filing Party: | |
| (4) | Date Filed: |
Nixxy, Inc.
1178 Broadway, 3rd Floor
New York, NY 10001
(877) 708-8868
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
To the stockholders of Nixxy, Inc.:
We are pleased to invite you to attend our Annual Meeting of the Stockholders (the “Annual Meeting”) of Nixxy, Inc., a Nevada corporation (the “Company”), which will be held at 11:00 a.m. Eastern time on December 23, 2026, virtually at https://www.virtualshareholdermeeting.com/NIXXY2026 for the following purposes:
| 1. | To elect five directors to our Board of Directors to serve until the next Annual Meeting of Stockholders or until their successors have been duly elected or appointed and qualified (“Director Appointments”); |
| 2. |
To ratify the appointment of KG CPA LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 (the “Auditor Appointment”);
|
| 3. | To approve an amendment to the Company’s Articles of Incorporation, as amended, to increase the number of authorized shares of Common Stock from 10,000,000 shares to 500,000,000 shares (the “Authorized Share Increase”); |
| 4. | To approve an amendment to the Company’s 2025 Equity Incentive Plan to increase the number of shares of Common Stock reserved for issuance thereunder from 125,000 shares to 250,000 shares, on a post-reverse stock split basis (the “Plan Amendment”); |
| 5. | To approve the adjournment of the Annual Meeting to a later date or time, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Annual Meeting, there are not sufficient votes to approve the Director Appointments, the Auditor Appointment, the Authorized Share Increase and/or the Plan Amendment (the “Adjournment”); and |
| 6. | To conduct any other business as may properly come before the meeting or any adjournment thereof. |
The Company’s board of directors (the “Board”) has fixed the close of business on November 2, 2026 as the date (the “Record Date”) for a determination of stockholders entitled to notice of, and to vote at, the Annual Meeting or any adjournment thereof.
If You Plan to Attend
Please take notice that the annual meeting of shareholders (the “Annual Meeting”) of Nixxy, Inc. (the “Company”) will be held on December 23, 2026, at 11:00 a.m., Eastern Standard Time. This year’s Annual Meeting will be a completely “virtual meeting” of shareholders. You will be able to attend the Annual Meeting, vote and submit your questions during the Annual Meeting via live webcast by visiting https://www.virtualshareholdermeeting.com/NIXXY2026. There is no pre-registration required; however, we encourage shareholders to allow adequate time to log in. You will not be able to attend the Annual Meeting in person.
| By the Order of the Board of Directors | ||
| /s/ David Kratochvil | ||
| David Kratochvil | ||
| Chairman |
Dated: November 18, 2026
Whether or not you expect to attend the virtual Annual Meeting, we urge you to vote your shares at your earliest convenience. This will ensure the presence of a quorum at the meeting. Promptly voting your shares via the Internet, by phone or by signing, dating, and returning the enclosed proxy card will save us the expenses and extra work of additional solicitation. An addressed envelope for which no postage is required if mailed in the United States is enclosed if you wish to vote by mail. Submitting your proxy now will not prevent you from voting your shares at the meeting if you desire to do so, as your proxy is revocable at your option. Your vote is important, so please act today!
Table of Contents
| Page | |
| Questions and Answers Regarding the Annual Meeting of Stockholders | 1 |
| Proposal 1. Approval of the Director Appointments | 6 |
| Proposal 2. Approval of the Auditor Appointment | 11 |
| Proposal 3: Approval of the Authorized Share Increase | 13 |
| Proposal 4. Approval of the Plan Amendment | 14 |
| Proposal 5. Approval of the Adjournment | 17 |
| Executive and Director Compensation | 18 |
| Security Ownership of Certain Beneficial Owners and Management | 20 |
| Certain Relationships and Related Transactions | 22 |
| Stockholder Proposals to be Presented at the Next Annual Meeting | 23 |
| Availability of Annual Report on Form 10-K | 23 |
| Stockholders Sharing the Same Last Name and Address | 24 |
| Where You Can Find More Information | 24 |
| i |
Nixxy, Inc.
1178 Broadway, 3rd Floor
New York, NY 10001
(877) 708-8868
ANNUAL MEETING OF STOCKHOLDERS
PROXY STATEMENT
This proxy statement (the “Proxy Statement”) is being sent to the holders of shares of voting stock of Nixxy, Inc., a Nevada corporation (the “Company”), in connection with the solicitation of proxies by our Board of Directors (the “Board”) for use at the Annual Meeting of Stockholders of the Company which will be held at 11:00 a.m. Eastern Time on December 23, 2026, virtually at https://www.virtualshareholdermeeting.com/NIXXY2026 (the “Annual Meeting”).
QUESTIONS AND ANSWERS REGARDING THE ANNUAL MEETING OF STOCKHOLDERS
Who is entitled to vote at the Annual Meeting?
The Board has fixed the close of business on November 2, 2026 as the record date (the “Record Date”) for a determination of the stockholders entitled to notice of, and to vote at, the Annual Meeting. As of the Record Date, there were 1,477,067 shares (on a post-Reverse Split basis) of common stock, par value $0.0001 per share (“Common Stock”) of the Company.
What matters will be voted on at the Annual Meeting?
The five (5) proposals that are scheduled to be considered and voted on at the Annual Meeting are as follows:
| 1. | To elect five directors to our Board of Directors to serve until the next Annual Meeting of Stockholders or until their successors have been duly elected or appointed and qualified (the “Director Appointments”); |
| 2. | To ratify the appointment of KG CPA LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 (the “Auditor Appointment”); |
| 3. | To approve an amendment to the Company’s Articles of Incorporation, as amended, to increase the number of authorized shares of Common Stock from 10,000,000 shares to 500,000,000 shares (the “Authorized Share Increase”); |
| 4. | To approve an amendment to the Company’s 2025 Equity Incentive Plan to increase the number of shares of Common Stock reserved for issuance thereunder from 125,000 shares to 250,000 shares, on a post-reverse stock split basis (the “Plan Amendment”); and |
| 5. | To approve the adjournment of the Annual Meeting to a later date or time, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Annual Meeting, there are not sufficient votes to approve the Director Appointments, Auditor Appointment, Authorized Share Increase and/or Plan Amendment (the “Adjournment”). |
| 1 |
Why are we seeking stockholder approval for these proposals?
Proposal No. 1: The Nevada Revised Statutes, as amended, require corporations to hold elections for directors each year.
Proposal No. 2: The Company appointed KG CPA LLP to serve as the Company’s independent auditors for the 2026 fiscal year. The Company elects to have its stockholders ratify such appointment.
Proposal No. 3: Under the Nevada Revised Statutes, an amendment to the Company’s Articles of Incorporation to increase the number of authorized shares of Common Stock requires the approval of the Company’s stockholders.
Proposal No. 4: Nasdaq Listing Rule 5635(c) requires stockholder approval of any material amendment to an equity compensation plan, including an increase in the number of shares reserved for issuance under the plan.
Proposal No. 5: To provide the Company additional opportunities to receive approval for Proposal Numbers 1, 2, 3 and 4 if necessary.
What are the Board’s voting recommendations?
The Board of Directors recommends that you vote “FOR” the Director Appointments, “FOR” the Auditor Appointment, “FOR” the Authorized Share Increase, “FOR” the Plan Amendment, and “FOR” the Adjournment.
What is the difference between holding shares as a record holder and as a beneficial owner?
If your shares are registered in your name with the Company’s transfer agent, Nevada Agency & Transfer Company you are the “record holder” of those shares. If you are a record holder, these proxy materials have been provided directly to you by the Company.
If your shares are held in a stock brokerage account, a bank or other holder of record, you are considered the “beneficial owner” of those shares held in “street name.” If your shares are held in street name, these proxy materials have been forwarded to you by that organization. As the beneficial owner, you have the right to instruct this organization on how to vote your shares.
Who may attend the Annual Meeting?
Record holders and beneficial owners may attend the Annual Meeting. If your shares are held in street name and you wish to vote at the Annual Meeting, you will need a “legal proxy” from your brokerage firm, bank, dealer or other similar organization showing your stock ownership as of the Record Date. Please see below for instructions on how to vote at the Annual Meeting if your shares are held in street name.
| 2 |
How do I vote?
If you are a stockholder of record, you may:
| 1. | Vote by Internet. The website address for Internet voting is on your proxy card. | |
| 2. | Vote by phone. The phone number for phone voting is on your proxy card. | |
| 3. | Vote by mail. Mark, date, sign and mail promptly the enclosed proxy card. | |
| 4. | Vote at the Annual Meeting. Attend the virtual Annual Meeting and vote online. If you vote by phone or internet, please DO NOT mail your proxy card. |
If you are a beneficial owner, you must follow the voting procedures of your nominee included with your proxy materials. If your shares are held by a nominee and you intend to vote at the Annual Meeting, please obtain a legal proxy from your nominee authorizing you to vote your shares.
What constitutes a quorum?
To carry on the business of the Annual Meeting, we must have a quorum. A quorum is present when one-third of the voting power of the issued and outstanding capital stock of the Company, as of the Record Date, is represented in person or by proxy. Shares owned by the Company are not considered outstanding or considered to be present at the Annual Meeting. Broker non-votes and abstentions are counted as present for the purpose of determining the existence of a quorum. As of the Record Date, there are a total of 1,477,067 votes (on a post-Reverse Split basis) that may be voted on each matter that may come before the Annual Meeting.
What happens if the Company is unable to obtain a quorum?
If a quorum is not present to transact business at the Annual Meeting or if we do not receive sufficient votes in favor of the proposals by the date of the Annual Meeting, the persons named as proxies may propose one or more adjournments of the Annual Meeting to permit continued solicitation of proxies.
What is a “broker non-vote”?
Broker non-votes occur with respect to shares held in “street name,” in cases where the record owner (for instance, the brokerage firm or bank) does not receive voting instructions from the beneficial owner and the record owner does not have the authority to vote those shares on a proposal.
Various national and regional securities exchanges applicable to brokers, banks, and other holders of record determine whether the record owner (for instance, the brokerage firm, or bank) is able to vote on a proposal if the record owner does not receive voting instructions from the beneficial owner. The record owner may vote on proposals that are determined to be routine under these rules and may not vote on proposals that are determined to be non-routine under these rules. If a proposal is determined to be routine, your broker, bank, or other holder of record is permitted to vote on the proposal without receiving voting instructions from you. The proposal to ratify the Auditor Appointment (Proposal 2) and the proposal to approve the Adjournment (Proposal 5) are routine matters and the record owner may vote your shares on these proposals if it does not get instructions from you.
| 3 |
The proposals for the Director Appointments (Proposal 1), the Authorized Share Increase (Proposal 3) and the Plan Amendment (Proposal 4) are non-routine and the record owner may not vote your shares on any of these proposals if it does not get instructions from you. If you do not provide voting instructions on these matters, a broker non-vote will occur. Broker non-votes and abstentions will each be counted towards the presence of a quorum. Broker non-votes will have no effect on the outcome of any proposal. Abstentions will have no effect on Proposal 1 but will have the same effect as a vote “AGAINST” Proposals 2, 3, 4 and 5.
How many votes are needed for each proposal to pass?
| Proposals | Vote Required | ||
| (1) | Approve the Director Appointments | Plurality of the votes cast by the shares entitled to vote in the election. The five persons receiving the greatest number of votes will be elected as directors. | |
| (2) | Approve the Auditor Appointment | Majority of the voting power present in person or by proxy and entitled to vote on the matter | |
| (3) | Approve the Authorized Share Increase | Majority of the voting power present in person or by proxy and entitled to vote on the matter | |
| (4) | Approve the Plan Amendment | Majority of the voting power present in person or by proxy and entitled to vote on the matter | |
| (5) | Approve the Adjournment. | Majority of the voting power present in person or by proxy and entitled to vote on the matter |
What constitutes outstanding shares entitled to vote?
At the close of business on the Record Date, there were 1,477,067 shares of Common Stock (on a post-Reverse Split basis) outstanding and entitled to vote as of the Record Date.
Is broker discretionary voting allowed and what is the effect of broker non-votes?
| Broker | |||||
| Discretionary | Effect of Broker Non- | ||||
| Proposals | Vote Allowed | Votes on the Proposal | |||
| (1) | Approve the Director Appointments | No | None | ||
| (2) | Approve the Auditor Appointment | Yes | None | ||
| (3) | Approve the Authorized Share Increase | No | None | ||
| (4) | Approve the Plan Amendment | No | None | ||
| (5) | Approve the Adjournment | Yes | None |
What is an Abstention?
An abstention is a stockholder’s affirmative choice to decline to vote on a proposal. Under Nevada law, abstentions are counted as shares present and entitled to vote at the Annual Meeting. Generally, unless provided otherwise by applicable law, our Bylaws provide that an action of our stockholders (other than the election of directors) is approved by the affirmative vote of a majority of the voting power of the shares present in person or represented by proxy at the meeting and entitled to vote on the subject matter. Accordingly, abstentions will have the same effect as a vote “AGAINST” Proposals 2, 3, 4 and 5. Votes marked as “ABSTAIN” on Proposal 1 will have no effect because directors are elected by plurality voting.
| 4 |
What are the voting procedures?
You may vote in favor of each proposal or against each proposal, or in favor of some proposals and against others, or you may abstain from voting on any of these proposals. You should specify your respective choices on the accompanying proxy card or your voting instruction form.
Is my proxy revocable?
You may revoke your proxy and reclaim your right to vote up to and including the day of the Annual Meeting by giving written notice to the Corporate Secretary of the Company, by delivering a proxy card dated after the date of the proxy or by voting at the virtual Annual Meeting. All written notices of revocation and other communications with respect to revocations of proxies should be addressed to: Nixxy, Inc., 1178 Broadway, 3rd Floor, New York, NY 10001, Attention: Corporate Secretary.
Who is paying for the expenses involved in preparing and mailing this proxy statement?
All of the expenses involved in preparing, assembling and mailing these proxy materials and all costs of soliciting proxies will be paid by the Company. In addition to the solicitation by mail, proxies may be solicited by the Company’s officers and regular employees by telephone or in person. Such persons will receive no compensation for their services other than their regular salaries. Arrangements will also be made with brokerage houses and other custodians, nominees and fiduciaries to forward solicitation materials to the beneficial owners of the shares held of record by such persons, and we may reimburse such persons for reasonable out of pocket expenses incurred by them in so doing. We may hire an independent proxy solicitation firm.
Could other matters be decided at the Annual Meeting?
Other than the Director Appointments, the Auditor Appointment, the Authorized Share Increase, the Plan Amendment, and the Adjournment proposal, no other matters will be presented for action by the stockholders at the Annual Meeting.
Do I have dissenters’ (appraisal) rights?
Appraisal rights are not available to the Company’s stockholders with any of the proposals brought before the Annual Meeting.
Interest of Officers and Directors in Matters to Be Acted Upon
Other than in their capacity as potential recipients of awards under the 2025 Equity Incentive Plan, which may be increased if the Plan Amendment is approved, none of the officers or directors have any interest in any of the matters to be acted upon at the Annual Meeting.
THE BOARD RECOMMENDS THAT STOCKHOLDERS VOTE “FOR” PROPOSALS 1, 2, 3, 4 AND 5.
| 5 |
PROPOSAL 1. ELECTION OF DIRECTORS
Our Board is currently composed of five (5) members. Directors hold office until the next Annual Meeting of Stockholders or until their earlier death, resignation, or removal, or until their successors are elected and qualified.
Information Regarding our Directors
Our Corporate Governance and Nominating Committee (the “Nominating Committee”) recommended, and our Board of Directors approved, David Kratochvil, Elsa Sung, Simon Paul Kearney, Joe Conlon and Robert Reda, each a current director, as nominees for election as directors at the 2026 Annual Meeting to hold office for a one-year term until our Annual Meeting of Stockholders to be held in 2027.
The director nominees have consented to be named as nominees in this proxy statement and have agreed to serve as directors if elected. Unless otherwise instructed, the proxy holders will vote the proxies received by them for the five (5) nominees named below. If any director nominee of the Company is unable or declines to serve as a director at the Annual Meeting, the proxies will be voted for any nominee designated by the present Board to fill the vacancy. The Board has no reason to believe that any of the nominees will be unavailable for election. The elected directors will hold office until the next Annual Meeting of Stockholders or until their earlier death, resignation, or removal, or until their successors are elected and qualified. There are no arrangements or understandings between any of our directors and any other person under which any director was selected to serve as a director of our Company. There are no family relationships among our directors or officers.
The following sets forth the persons nominated by the Board for election and certain information concerning those individuals:
| Director Nominee | Age | Position | Director Since | |||
| Simon Paul Kearney | 60 | Director | June 2026 | |||
| Joe Conlon | 45 | Director | August 2026 | |||
| Robert Reda | 57 | Director | October 2026 | |||
| Elsa Sung | 52 | Chief Financial Officer and Director | January 2025 | |||
| David Kratochvil | 61 | Chief Executive Officer and Director | January 2025 |
Simon Paul Kearney – Mr. Kearney has served on the Board since June 2026. Mr. Kearney is a senior business owner-operator with decades of leadership in hospitality, commercial real estate, asset management, and strategic growth initiatives. Since January 2012, he has served as President and CEO of Kilkenny LLC, and since January 2015, he has served as President and CEO of Killane LLC, where he provided management duties for real estate holdings. He also served as President of Kilnock, Inc. from March 2003 until September 2023.
Joe Conlon – Mr. Conlon has served on the Board and as Chairman of the Audit Committee since August 2026. Mr. Conlon is a Fellow Chartered Accountant (FCA) with extensive leadership experience in financial governance, audit oversight, and multinational corporate finance. He has held senior finance roles across the public sector, global public companies, and higher education, bringing deep expertise in financial reporting, internal controls, risk management, and regulatory compliance. Mr. Conlon currently serves as National School Sector Finance Manager with Ireland’s Financial Support Services Unit (FSSU), where he is responsible for national-level financial governance frameworks, advisory services to boards, and oversight of budgeting, financial controls, and risk management across a large, regulated education system. In parallel, Mr. Conlon serves as a Lecturer in Finance and Taxation at the Technological University of Shannon, where he is responsible for curriculum development, financial education, and academic quality assurance across finance, accounting, and business disciplines. Previously, Mr. Conlon held senior finance leadership roles with Imperial Brands PLC, leading budgeting, statutory reporting, audit support, and regulatory compliance across multinational environments. Earlier experience includes Pfizer Europe, Macquarie Aviation and Electronics Asset Finance.
| 6 |
Robert Reda – Mr. Reda has served on the Board since October 2026, as Chair of the Nominating Committee and as a member of the Audit Committee and the Compensation Committee. Mr. Reda is the founder and principal of Robert L. Reda, P.C. (est. 1996) and is a real estate attorney with over 30 years of experience specializing exclusively in complex real estate transactions, project development, title, land use, and contract matters across New York and Connecticut. He founded and led a dedicated practice that has facilitated thousands of residential, commercial, and mixed-use closings for buyers, sellers, investors, foreign nationals, and major lenders. Mr. Reda brings operational insight into site acquisition, due diligence, risk mitigation, and stakeholder coordination. Mr. Reda received a BA from Allegheny College in 1991 and a JD from New York Law School in 1994. He has been admitted to practice law in state and federal courts in New York since 1995 and in Connecticut since 1996.
Elsa Sung – Ms. Sung has served on the Board since January 2025 and as our Chief Financial Officer since August 2026. She has over 20 years of corporate financial and accounting experience, including serving as the chief financial officer of a Nasdaq-listed company. Since February 2017, she has been a managing member of Canvas Group, Inc, a boutique financial advisory and business consulting firm. From April 2013 until December 2019, she worked as a senior executive advisor in the areas of international business development and mergers and acquisitions for Zhongmai Group. From May 2007 to January 2013, Ms. Sung was Senior Vice President of CFO Oncall, Inc., providing chief financial officer and consulting services to various companies. She also served as Chief Financial Officer of Jiangbo Pharmaceuticals, Inc. (Nasdaq:JCBO) from October 2007 until March 2011. Ms. Sung was an Audit Manager from September 2005 to May 2007 at Sherb & Co., responsible for managing, monitoring, as well as performing audits for domestic and international clients. From September 2002 to July 2005, Ms. Sung was with Ernst & Young, LLP as a Senior Auditor in the Assurance and Advisory Business Service Group. She received her Master of Business Administration and Bachelor of Science, in accounting from Florida Atlantic University. She also holds a Bachelor of Arts in Sociology from National Chengchi University in Taipei, Taiwan. She earned a CPA license in the state of Georgia (inactive).
David Kratochvil – Mr. Kratochvil has served on the Board since January 2025 and as our Chief Executive Officer since July 2026. Mr. Kratochvil, has over thirty years of Wall Street experience ranging from venture capital, private equity and emerging market equity investing to investment banking and structuring tax-advantaged deals. Since January 2017, Mr. Kratochvil has served as the managing partner Vista Capital Advisors where he consults on various projects and serves as an outsourced CFO for early-stage companies. Additionally, since April 2024, he has served as the chief financial officer of Pertexa Health Tech Inc. From April 2023 until April 2024, he served as chief financial officer of Northann Corp (NYSE: NCL). Since January 2020, he has also served as Managing Director of Kenmar Securities, LLC, an investment banker focusing on life science, technology and real estate transactions. From January 2019 until December 2021, Mr. Kratochvil was CEO of Ikigai Biotech Group, Inc., a developing biotech company focused on using 3D bioprinting to tackle T1 diabetes and kidney disease.
From June 2017 until December 2019, he worked at Oberon Securities as a Managing Director focusing on healthcare and life science transactions. From 2015 until 2017, he served as chief financial officer of VolitionRx (NYSE: VNRX), a multi-national medical diagnostics company developing simple blood-based tests to accurately diagnose a range of cancers. From 2008 until 2015, he served as Managing Director in the corporate finance department at Euro Pacific Capital, Inc. From 1997 until 1999, he served as portfolio manager at Omega Advisors. From 1994 until 1997, he served as director at Merrill Lynch Asset Management.
Mr. Kratochvil holds an MBA in finance and international business from the University of Chicago’s Booth School of Business and a B.S. in Economics from The Wharton School at the University of Pennsylvania. He holds FINRA 7, 14, 24, 63, 79, 86 and 87 registrations.
Family Relationships
There are no family relationships among our directors and/or executive officers.
| 7 |
Director Independence
Our Board has reviewed the materiality of any relationship that each of our directors has with us, either directly or indirectly. Based on this review, our Board has affirmatively determined that each of Simon Paul Kearney, Joe Conlon and Robert Reda, current members of our Board, meet the independence requirements under the Listing Rules of The Nasdaq Stock Market LLC (the “Nasdaq Listing Rules”). David Kratochvil and Elsa Sung are not independent because they serve as our Chief Executive Officer and Chief Financial Officer, respectively.
Board Committees
The Board currently has the following standing committees: the Audit Committee, the Compensation Committee, and the Nominating Committee.
The following table identifies the independent and non-independent current Board and committee members:
| Name | Audit | Compensation | Nominating | Independent | ||||
| David Kratochvil | ||||||||
| Elsa Sung | ||||||||
| Simon Paul Kearney | X | Chairman | X | X | ||||
| Joe Conlon | Chairman | X | X | X | ||||
| Robert Reda | X | X | Chairman | X |
Board and Committee Meetings
During the year ended December 31, 2025, the Board had 15 meetings, the Audit Committee had 4 meetings, the Compensation Committee had 4 meetings, and the Nominating Committee had 1 meeting.
There were no directors (who were incumbent at the time), who attended fewer than 75 percent of the aggregate total number of Board meetings and meetings of the Board committees of which the director was a member during the applicable period.
Audit Committee
Management has the primary responsibility for the financial statements and the reporting process, including the system of internal controls. The Audit Committee reviews the Company’s financial reporting process on behalf of the Board and administers our engagement of the independent registered public accounting firm. The Audit Committee meets with the independent registered public accounting firm, with and without management present, to discuss the results of its examinations, the evaluations of our internal controls, and the overall quality of our financial reporting.
Audit Committee Financial Expert
Our Board has determined that Joe Conlon is qualified as an Audit Committee Financial Expert, as that term is defined under the rules of the Securities and Exchange Commission (the “SEC”) and in compliance with the Sarbanes-Oxley Act.
| 8 |
Compensation Committee
The function of the Compensation Committee is to determine the compensation of our executive officers. The Compensation Committee has the power to set performance targets for determining annual bonuses payable to executive officers and may review and make recommendations with respect to stockholder proposals related to compensation matters.
Nominating Committee
The responsibilities of the Nominating Committee include the identification of individuals qualified to become Board members, the selection of nominees to stand for election as directors, the oversight of the selection and composition of committees of the Board, establishing procedures for the nomination process, oversight of possible conflicts of interests involving the Board and its members, developing corporate governance principles, and the oversight of the evaluations of the Board and management. The Nominating Committee will consider director candidates recommended by stockholders that are submitted in accordance with the procedures described under “Stockholder Proposals to be Presented at the Next Annual Meeting” and will evaluate such candidates in good faith on the same basis as other candidates.
Board Diversity
While we do not have a formal policy on diversity, our Board considers diversity to include the skill set, background, reputation, type and length of business experience of our Board members as well as a particular nominee’s contributions to that mix. Our Board believes that diversity promotes a variety of ideas, judgments and considerations to the benefit of our Company and stockholders. Although there are many other factors, the Board primarily focuses on public company board experience, knowledge of our industry, or background in finance or technology, and experience operating growing businesses.
Board Leadership Structure
Our Board has not adopted a formal policy regarding the separation of the offices of Chief Executive Officer and Chairman of the Board. Rather, the Board believes that different leadership structures may be appropriate for our Company at different times and under different circumstances, and it prefers flexibility in making this decision based on its evaluation of the relevant facts at any given time.
Board Role in Risk Oversight
Our Board bears responsibility for overseeing our risk management function. Our management keeps the Board apprised of material risks and provides to directors access to all information necessary for them to understand and evaluate the effect of these risks, individually or in the aggregate, on our business, and how management addresses them. Our Chief Executive Officer works closely together with the Board once material risks are identified on how to best address such risks. If the identified risks present an actual or potential conflict with management, our independent directors may conduct the assessment.
| 9 |
Code of Ethics
Our Board has adopted a Code of Ethics that applies to all of our employees, including our Chief Executive Officer and Chief Financial Officer. Although not required, the Code of Ethics also applies to our directors. The Code of Ethics provides written standards that we believe are reasonably designed to deter wrongdoing and promote honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships, full, fair, accurate, timely and understandable disclosure and compliance with laws, rules and regulations, including insider trading, corporate opportunities and whistleblowing or the prompt reporting of illegal or unethical behavior. We will provide a copy of our Code of Ethics, without charge, upon request in writing to Nixxy, Inc. at 1178 Broadway, 3rd Floor, New York, NY 10001, Attention: Corporate Secretary.
Delinquent Section 16(a) Reports
Section 16(a) of the Exchange Act requires our directors, executive officers, and persons who own more than 10% of our Common Stock to file initial reports of ownership and changes in ownership of our Common Stock with the SEC. These individuals are required by the regulations of the SEC to furnish us with copies of all Section 16(a) forms they file. Based solely on a review of the copies of the forms furnished to us none of our directors, executive officers, and persons who own more than 10% of our Common Stock failed to comply with Section 16(a) filing requirements, except a Form 3 from each of Mr. Yang, Mr. Raichura and Mr. Schmidt.
Hedging Policy
We do not currently have any practices or policies regarding hedging or offsetting any decrease in the market value of our equity securities.
Communication with our Board
Although we do not have a formal policy regarding communications with the Board, stockholders may communicate with the Board by writing to us at Nixxy, Inc., 1178 Broadway, 3rd Floor, New York, NY 10001, Attention: Corporate Secretary. Stockholders who would like their submission directed to a member of the Board may so specify, and the communication will be forwarded, as appropriate.
THE BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” ALL OF THE NOMINEES FOR ELECTION AS DIRECTORS.
| 10 |
PROPOSAL 2. RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Audit Committee of the Board has appointed KG CPA LLP (“KG”) as our independent registered public accounting firm for the fiscal year ending December 31, 2026. We are not required to seek stockholder approval for the appointment of our independent registered public accounting firm, however, the Audit Committee and the full Board believe it is sound corporate practice to seek such approval. If the appointment is not ratified, the Audit Committee will investigate the reasons for stockholder rejection and will re-consider the appointment. Even if the selection is ratified, the Audit Committee in its discretion may direct the appointment of a different independent registered public accounting firm at any time during the year if it determines that such change would be in the best interests of us and our stockholders.
Representatives of KG are not expected to be present at the Annual Meeting. However, we will provide contact information for KG to any stockholders who would like to contact the firm with questions.
The following table presents fees for professional services rendered by KG CPA LLP, our current independent registered public accounting firm, and Salberg & Company, P.A. and HTL International, LLC, our former independent registered public accounting firms, for the fiscal years ended December 31, 2025 and 2024.
| (in thousands) | Fiscal Year Ended December 31, 2025 | Fiscal Year Ended December 31, 2024 | ||||||
| Audit fees - KG CPA LLP | $ | 90 | $ | – | ||||
| Audit fees - HTL International | 106 | – | ||||||
| Audit fees - Salberg & Company, P.A. | 22 | 133 | ||||||
| Audit related fees - HTL International | 10 | |||||||
| Audit related fees - Salberg & Company, P.A. | 18 | 10 | ||||||
| Tax fees | – | – | ||||||
| All other fees | – | – | ||||||
| Total | $ | 246 | $ | 143 | ||||
| · | Audit-Related Fees - consist of assurance and related services that are reasonably related to the performance of the audit or review of the Company’s financial statements and are not reported above under “Audit Fees.” These services include consultation regarding accounting and financial reporting matters. | |
| · | Tax Fees - consist of professional services rendered for tax compliance, tax advice, and tax planning. No tax fees were incurred during fiscal 2025 or 2024. | |
| · | All Other Fees - consist of fees billed for products and services other than those reported above. No such fees were incurred during fiscal 2025 or 2024. |
| 11 |
Policy on Pre-Approval of Audit and Permissible Non-audit Services of Independent Auditors
Consistent with the SEC policies regarding auditor independence, our Audit Committee has responsibility for appointing, setting compensation and overseeing the work of the independent auditor. In recognition of this responsibility, our Audit Committee has established a policy to pre-approve all audit and permissible non-audit services provided by the independent auditor.
Prior to engagement of the independent auditor for the next year’s audit, management will submit an aggregate of services expected to be rendered during that year for each of the four categories of services described above (audit, audit-related, tax and all other services) to the Audit Committee for approval.
THE BOARD OF DIRECTORS RECOMMENDS THAT THE STOCKHOLDERS VOTE “FOR” THIS PROPOSAL 2.
| 12 |
PROPOSAL 3. APPROVAL OF AN AMENDMENT TO OUR ARTICLES OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK
Overview
Pursuant to a unanimous written consent effective as of October 20, 2026, our Board approved a reverse stock split of our Common Stock at a ratio of one-for-twenty (1:20), effective at 12:01 a.m. Eastern Time on November 20, 2026 (the “Reverse Split”), and a corresponding decrease in the number of authorized shares of Common Stock from 200,000,000 shares to 10,000,000 shares. Upon the effectiveness of the Reverse Split, our Articles of Incorporation, as amended (the “Articles”), will authorize the issuance of 10,000,000 shares of Common Stock.
Our Board has approved, declared advisable and recommends that our stockholders approve an amendment to the Articles, to be effected by the filing of a Certificate of Amendment with the Secretary of State of the State of Nevada, to increase the number of authorized shares of Common Stock from 10,000,000 shares to 500,000,000 shares. The Authorized Share Increase will not change the par value of the Common Stock, which will remain $0.0001 per share.
Reasons for the Authorized Share Increase
Our Board believes the Authorized Share Increase is advisable and in the best interests of the Company and its stockholders in order to provide the Company with flexibility to issue shares for capital raising, strategic transactions, equity compensation and other general corporate purposes, without the delay and expense of seeking further stockholder approval, except as required by applicable law or the rules of any stock exchange on which our securities are then listed.
Effects of the Authorized Share Increase
The additional shares of Common Stock would have the same rights as the shares of Common Stock currently authorized. Our stockholders do not have preemptive rights, and the issuance of additional shares of Common Stock, other than in a stock split or stock dividend, could dilute the voting power, ownership percentage and, depending on the issuance price, earnings per share and book value per share of existing stockholders. The additional authorized shares could also, under certain circumstances, be used to make a change in control of the Company more difficult; however, the Authorized Share Increase is not being proposed in response to any known effort to acquire control of the Company. If the Authorized Share Increase is approved, it will become effective upon the filing of the Certificate of Amendment with the Secretary of State of the State of Nevada, which the Company expects to file promptly after the Annual Meeting. Stockholders are not entitled to dissenters’ or appraisal rights in connection with the Authorized Share Increase.
Vote Required
The affirmative vote of a majority of the voting power present in person or represented by proxy at the Annual Meeting and entitled to vote on the matter is required to approve the Authorized Share Increase. Abstentions will have the same effect as a vote “AGAINST” this Proposal 3. Broker non-votes, if any, will have no effect on the outcome of this Proposal 3.
THE BOARD OF DIRECTORS RECOMMENDS THAT THE STOCKHOLDERS VOTE “FOR” THIS PROPOSAL 3.
| 13 |
PROPOSAL 4. APPROVAL OF AN AMENDMENT TO THE 2025 EQUITY INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES RESERVED FOR ISSUANCE
Overview
Our Board, upon the recommendation of the Compensation Committee, has approved, declared advisable and recommends that our stockholders approve an amendment to the Nixxy, Inc. 2025 Equity Incentive Plan (the “2025 Plan” or the “Plan”) to increase the number of shares of Common Stock reserved for issuance thereunder from 125,000 shares to 250,000 shares, in each case on a post-Reverse Split basis (the “Plan Amendment”). The Plan currently reserves 2,500,000 shares of Common Stock for issuance, which reserve will be proportionately adjusted to 125,000 shares upon the effectiveness of the Reverse Split pursuant to the adjustment provisions of the Plan. Other than the increase in the number of shares reserved for issuance, the Plan Amendment effects no other material changes to the Plan. If approved by our stockholders, the Plan Amendment will become effective as of the date of the Annual Meeting.
Reasons for the Plan Amendment
Our Board believes the Plan Amendment is necessary to provide sufficient capacity to attract, retain and incentivize our employees, directors and consultants. We provide long-term incentives to these service providers in the form of equity compensation, which we believe aligns their interests with the interests of our stockholders and fosters an ownership mentality that drives decision-making for the long-term health of the Company. Upon the effectiveness of the Reverse Split, the Plan’s share reserve will be proportionately reduced to 125,000 shares, which our Board believes is insufficient to satisfy our expected equity grant requirements. Having an adequate number of shares available for future grants is necessary to promote our long-term success and the creation of stockholder value by (i) enabling us to continue to attract and retain the services of key employees and other service providers who would be eligible to receive grants; (ii) aligning participants’ interests with stockholders’ interests through incentives that are based upon the performance of our Common Stock; (iii) motivating participants, through equity incentive awards, to achieve long-term growth in the Company’s business; and (iv) providing a long-term equity incentive program that is competitive with other companies with whom we compete for talent.
The Plan Amendment, as proposed, is attached as Appendix A to this Proxy Statement. Stockholders are urged to review it together with the following information, which is qualified in its entirety by reference to the complete text of the Plan. If there is any inconsistency between the description of the Plan included in this Proxy Statement and the terms of the Plan, the terms of the Plan shall govern.
2025 Equity Incentive Plan
On November 6, 2025, our Board approved the 2025 Plan, covering 2,500,000 shares of Common Stock (125,000 shares on a post-Reverse Split basis). The purpose of the 2025 Plan is to advance the interests of the Company by enhancing the ability of the Company to attract and retain qualified employees, consultants, officers, and directors, by creating incentives and rewards for their contributions to the success of the Company and its related corporations. The 2025 Plan is administered by our Board or by the Compensation Committee. The following awards may be granted under the 2025 Plan:
| · | incentive stock options (“ISOs”) | |
| · | non-qualified options (“NSOs”) |
| · | awards of our restricted common stock | |
| · | stock appreciation rights (“SARs”) | |
| · | restricted stock units (“RSUs”) |
| 14 |
Any option granted under the 2025 Plan must provide for an exercise price of not less than 100% of the fair market value of the underlying shares on the date of grant and not less than $4.00 per share, but the exercise price of any ISO granted to an eligible employee owning more than 10% of our outstanding common stock must not be less than 110% of fair market value on the date of the grant. The plans further provide that with respect to ISOs the aggregate fair market value of the common stock underlying the options which are exercisable by any option holder during any calendar year cannot exceed $100,000. The exercise price of any NSO granted under the 2025 Plan is determined by the Board at the time of grant but must be at least equal to fair market value on the date of grant. The term of each plan option and the manner in which it may be exercised is determined by the Board or the Compensation Committee, provided that no option may be exercisable more than 10 years after the date of its grant and, in the case of an incentive option granted to an eligible employee owning more than 10% of the common stock, no more than five years after the date of the grant. The terms of any other type of award under the 2025 Plan are determined by the Board at the time of grant. Subject to the limitation on the aggregate number of shares issuable under the plans, there is no maximum or minimum number of shares as to which a stock grant or plan option may be granted to any person.
Summary of Material Features of the Plan
The following summary of the material terms of the Plan is qualified in its entirety by the full text of the Plan, a copy of which is included as Appendix A to this Proxy Statement.
Plan Administration
The Plan may be administered by the entire Board or by the Compensation Committee. Once appointed, the Compensation Committee shall continue to serve until otherwise directed by the Board. A majority of the members of the Compensation Committee shall constitute a quorum, and all determinations of the Compensation Committee shall be made by the majority of its members present at a meeting. Any determination of the Compensation Committee under the Plan may be made without notice or meeting of the Compensation Committee by a writing signed by all of the Compensation Committee members. Subject to ratification of the grant of each Stock Right by the Board (but only if so required by applicable state law), and subject to the terms of the Plan, the Compensation Committee shall have the authority to (i) determine the employees of the Company and Related Corporations (from among the class of employees eligible under Section 3 to receive ISOs) to whom ISOs may be granted, and to determine (from among the class of individuals and entities eligible under Section 3 to receive Non-Qualified Options, Restricted Stock, RSUs and SARs) to whom Non-Qualified Options, Restricted Stock, RSUs and SARs may be granted; (ii) determine when Stock Rights may be granted; (iii) determine the exercise prices of Stock Rights other than Restricted Stock and RSUs, which shall not be less than the Fair Market Value; (iv) determine whether each Option granted shall be an ISO or a Non-Qualified Option; (v) determine when Stock Rights shall become exercisable, the duration of the exercise period, and when each Stock Right shall vest; (vi) determine whether restrictions such as repurchase options are to be imposed on shares subject to or issued in connection with Stock Rights, and the nature of such restrictions, if any, and (vii) interpret the Plan and promulgate and rescind rules and regulations relating to it. The interpretation and construction by the Compensation Committee of any provisions of the Plan or of any Stock Right granted under it shall be final, binding, and conclusive unless otherwise determined by the Board. The Compensation Committee may from time to time adopt such rules and regulations for carrying out the Plan as it may deem best.
This Plan is intended to comply in all respects with Rule 16b-3 and its successor rules as promulgated under Section 16(b) of the Exchange Act for participants who are subject to Section 16 of the Exchange Act. To the extent any provision of the Plan or action by the Plan administrators fails to so comply, it shall be deemed null and void to the extent permitted by law and deemed advisable by the Plan administrators. Provided, however, such exercise of discretion by the Plan administrators shall not interfere with the contract rights of any grantee. In the event that any interpretation or construction of the Plan is required, it shall be interpreted and construed in order to ensure, to the maximum extent permissible by law, that such grantee does not violate the short-swing profit provisions of Section 16(b) of the Exchange Act and that any exemption available under Rule 16b-3 or other rule is available.
| 15 |
Eligibility
Awards under the 2025 Plan, other than incentive stock options, may be granted to employees (including officers and directors) of the Company or a parent or subsidiary, members of our Board, or consultants engaged to render bona fide services to the Company or a parent or subsidiary. Incentive stock options may be granted only to employees of the Company or a subsidiary, provided the services (a) are not in connection with the offer or sale of securities in a capital-raising transaction, and (b) do not directly promote or maintain a market for the Company’s securities, in each case, within the meaning of Form S-8 promulgated under the Securities Act, and provided further, that a Consultant will include only those persons to whom the issuance of Shares may be registered under Form S-8 promulgated under the Securities Act. Those Officers and directors of the Company who are not employees may not be granted ISOs under the Plan. Subject to compliance with Rule 16b-3 and other applicable securities laws, Non-Qualified Options, Restricted Stock, RSUs, and SARs may be granted to any director (whether or not an employee), Officers, employees, or consultants of the Company or any Related Corporation. The Compensation Committee may take into consideration a recipient’s individual circumstances in determining whether to grant an ISO, a Non-Qualified Option, Restricted Stock, RSUs, or a SAR. Granting of any Stock Right to any individual or entity shall neither entitle that individual or entity to, nor disqualify him from participation in, any other grant of Stock Rights.
Shares Available for Awards; Limits on Awards
Prior to giving effect to the Reverse Split, the maximum number of shares of our Common Stock that may be subject to awards under the 2025 Plan is 2,500,000, which will be proportionately adjusted to 125,000 shares upon the effectiveness of the Reverse Split. If the Plan Amendment is approved, the maximum number of shares of our Common Stock that may be subject to awards under the 2025 Plan will be 250,000 (on a post-Reverse Split basis). The maximum number of shares that are subject to awards under the 2025 Plan is subject to an annual increase equal to the lesser of (A) five percent (5%) of the shares of Common Stock outstanding on the final day of the immediately preceding calendar year, and (B) such smaller number of shares of Common Stock as determined by the Board.
Types of Awards That May Be Granted
The 2025 Plan will provide to (a) Officers and other employees of the Company and its Related Corporations opportunities to purchase common stock, par value $0.0001 (“Common Stock”) of the Company pursuant to Options granted hereunder which qualify as incentive stock options (“ISOs”) under Section 422(b) of the Internal Revenue Code of 1986 (the “Code”), (b) directors, Officers, employees, and consultants of the Company and Related Corporations opportunities to purchase Common Stock in the Company pursuant to options granted hereunder which do not qualify as ISOs (“Non-Qualified Options”); (c) directors, Officers, employees, and consultants of the Company and Related Corporations opportunities to receive shares of Common Stock of the Company which normally are subject to restrictions on sale (“Restricted Stock”); (d) directors, Officers, employees, and consultants of the Company and Related Corporations opportunities to receive grants of stock appreciation rights (“SARs”); and (e) directors, Officers, employees, and consultants of the Company and Related Corporations opportunities to receive grants of restricted stock units (“RSUs”). ISOs and Non-Qualified Options are referred to hereafter as (“Options”). Options, Restricted Stock, SARs, and RSUs are sometimes referred to hereafter collectively as (“Stock Rights”). Any of the Options and/or Stock Rights may in the Compensation Committee’s discretion be issued in tandem to one or more other Options and/or Stock Rights to the extent permitted by law.
Vote Required
The affirmative vote of a majority of the voting power present in person or represented by proxy at the Annual Meeting and entitled to vote on the matter is required to approve the Plan Amendment. Abstentions will have the same effect as a vote “AGAINST” this Proposal 4. Broker non-votes, if any, will have no effect on the outcome of this Proposal 4.
THE BOARD OF DIRECTORS RECOMMENDS THAT THE STOCKHOLDERS VOTE “FOR” THIS PROPOSAL 4.
| 16 |
PROPOSAL 5. APPROVAL OF THE ADJOURNMENT
General
The Company is asking stockholders to approve, if necessary, adjournment of the Annual Meeting to solicit additional proxies in favor of the Director Appointments, the Auditor Appointment, the Authorized Share Increase and/or the Plan Amendment. Any adjournment of the Annual Meeting for the purpose of soliciting additional proxies will allow stockholders who have already sent in their proxies to revoke them at any time prior to the time that the proxies are used.
Vote Required
The affirmative vote of a majority of the voting power present in person or represented by proxy at the Annual Meeting and entitled to vote on the matter is required to approve the Adjournment proposal. Abstentions will have the same effect as a vote “AGAINST” this Proposal 5. Broker non-votes, if any, will have no effect on the outcome of this Proposal 5.
THE BOARD OF DIRECTORS RECOMMENDS THAT THE STOCKHOLDERS VOTE “FOR” THIS PROPOSAL 5.
| 17 |
EXECUTIVE AND DIRECTOR COMPENSATION
Summary Compensation Table
The following table sets forth information concerning compensation awarded to, earned by, or paid to our Named Executive Officers for the fiscal years ended December 31, 2025 and 2024.
For purposes of this disclosure, “Named Executive Officers” include (i) our principal executive officer serving during fiscal 2025 and (ii) our two most highly compensated executive officers other than the principal executive officer who were serving as executive officers on December 31, 2025.
Summary Compensation Table
| Name and Principal Position | Fiscal Year | Salary ($) | Bonus ($) | Stock Awards ($)(1) | Option Awards ($)(1) | Non-Equity Incentive Plan Compensation ($) | All Other Compensation ($) | Total ($) | ||||||||||||||||||||||
| Mike Schmidt, | 2025 | 105,000 | – | 174,000 | – | – | – | 279,000 | ||||||||||||||||||||||
| former Chief Executive Officer (1) | 2024 | – | – | – | – | – | – | – | ||||||||||||||||||||||
| MeiLin Yu, | 2025 | 14,000 | – | – | – | – | – | 14,000 | ||||||||||||||||||||||
| former Chief Financial Officer (2) | 2024 | – | – | – | – | – | – | – | ||||||||||||||||||||||
| Miles Jennings, | 2025 | 230,000 | 332,581 | – | – | 30,000 | 592,581 | – | ||||||||||||||||||||||
| former Chief Executive Officer (3) | 2024 | 200,082 | – | 336,449 | – | – | – | 536,531 | ||||||||||||||||||||||
| Evan Sohn, | 2025 | – | – | 774,300 | – | – | 60,000 | 834,300 | ||||||||||||||||||||||
| former Chief Executive Officer | 2024 | 21,581 | – | 336,449 | – | – | 37,000 | 395,030 | ||||||||||||||||||||||
| Adam Yang, | 2025 | 103,326 | – | 105,500 | – | – | – | 208,826 | ||||||||||||||||||||||
| former Chief Financial Officer | 2024 | 31,332 | – | – | – | – | – | 31,332 | ||||||||||||||||||||||
| Debra Chen Volpone, | 2025 | 5,000 | – | – | – | – | 375,000 | 380,000 | ||||||||||||||||||||||
| former Chief Executive Officer | 2024 | – | – | – | – | – | – | – | ||||||||||||||||||||||
| (1) | Mr. Schmidt served as Chief Executive Officer from May 2025 until July 2026. |
| (2) | Ms. Yu served as our Chief Financial Officer from December 2025 until August 2026. |
| (3) | Mr. Jennings served as Interim Chief Executive Officer from February 2025 to May 2025 and previously served as President and Chief Operating Officer. |
The amounts reported in the “Stock Awards” column represent the grant date fair value of awards computed in accordance with ASC 718. The assumptions used in calculating these amounts are described in Note 9 to the consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.
Named Executive Officer Employment Agreements
Yu-san “Debra” Chen Volpone
In January 2025, the Company entered into an employment agreement with Yu-san “Debra” Chen Volpone. In connection with Chen Volpone’s appointment as the Company’s Chief Executive Officer of the Company, effective January 1, 2025, the Company entered into an Employment Agreement (the “Employment Agreement”) with Ms. Chen Volpone for a term of one year (the “Initial Term”), with an automatic six-month extension unless either the Company or Ms. Chen Volpone provide written notice no more than ninety (90) days before and no less than ten (10) days prior to the expiration of the Initial Term. Ms. Chen Volpone shall receive a salary during the Initial Term of $350,000.
| 18 |
In February 2025, Ms. Volpone resigned as Chief Executive Officer.
Mike Schmidt
In May 2025, the Company entered into an employment agreement with Mr. Mike Schmidt to serve as Chief Executive Officer with an initial base salary of $10,000 per month and an award of 100,000 restricted stock units vesting quarterly over twelve months.
Miles Jennings
In December 2025, in connection with his separation from the Company, Mr. Miles Jennings received $30,000 cash payments and 30,000 restricted stock units that vested immediately pursuant to a separation agreement.
Compensation of Non-Employee Directors
The following table sets forth compensation paid to our non-employee directors for the fiscal year ended December 31, 2025.
| Name | Year | Fees Earned or Paid in Cash ($) | Equity Awards ($) | All Other Compensation ($) | Total ($) | |||||||||||||
| Lillian Mbeki | 2025 | 30,000 | 608,000 | – | 638,000 | |||||||||||||
| 2024 | 16,667 | – | – | 16,667 | ||||||||||||||
| Elsa Sung | 2025 | 36,000 | 608,000 | – | 644,000 | |||||||||||||
| 2024 | – | – | – | – | ||||||||||||||
| David Kratochvil | 2025 | 30,000 | 608,000 | 638,000 | ||||||||||||||
| 2024 | – | – | – | – | ||||||||||||||
| Ashissh Raichura | 2025 | 22,500 | 170,000 | 192,500 | ||||||||||||||
| 2024 | – | – | – | – | ||||||||||||||
Outstanding Equity Awards at December 31, 2025
As of December 31, 2025, an aggregate of 137,499 shares of the Company's common stock subject to granted director equity awards remained unvested.
The Board has not established policies and practices (whether written or otherwise) regarding the timing of option grants or other awards in relation to the release of material nonpublic information (“MNPI”) and do not take MNPI into account when determining the timing and terms of stock option or other equity awards to executive officers. The Company does not time the disclosure of MNPI, whether positive or negative, for the purpose of affecting the value of executive compensation.
| 19 |
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
Except as specifically noted, the following table sets forth information with respect to the beneficial ownership of our Common Stock as of November 2, 2026, of:
| · | each of our directors and executive officers; and |
| · | each person known to us to beneficially own 5% of our Common Stock on an as-converted basis. |
The calculations in the table are based on 1,477,067 common shares issued and outstanding as of November 2, 2026, on a post-Reverse Split basis.
Beneficial ownership is determined in accordance with the rules and regulations of the SEC. In computing the number of shares beneficially owned by a person and the percentage ownership of that person, we have included shares that the person has the right to acquire within 60 days, including through the exercise of any option, warrant or other right or the conversion of any other security. These shares, however, are not included in the computation of the percentage ownership of any other person. Unless otherwise indicated, the address for each beneficial owner listed in the table below is c/o Nixxy, Inc., 1178 Broadway, 3rd Floor, New York, NY 10001.
| Name of Beneficial Owner | No. of Shares Beneficially Owned |
% of Class | ||||||
| David Kratochvil | 10,875 | * | ||||||
| Elsa Sung | 9,375 | * | ||||||
| Simon Paul Kearney | 3,125 | * | ||||||
| Joe Conlon | 2,709 | * | ||||||
| Robert Reda | – | * | ||||||
| All executive officers and directors as a group (5 persons) | 26,084 | 1.8% | ||||||
| * | Less than 1%. |
| 20 |
Securities Authorized for Issuance under Equity Compensation Plans
The following table sets forth information as of December 31, 2025, with respect to our compensation plans under which equity securities may be issued.
| Plan Category | Number of Securities to be Issued upon Exercise of Outstanding Options, Warrants, and Rights | Weighted- Average Exercise Price of Outstanding Options, Warrants and Rights | Number of Securities Remaining Available for Future Issuance under Equity Compensation Plans (Excluding Securities Reflected in Column (a)) | |||||||||
| Equity compensation plans approved by security holders: | (a) | (b) | (c) | |||||||||
| 2017 Equity Incentive Plan (1) | 3,000 | 36.00 | 84,200 | |||||||||
| 2021 Equity Incentive Plan (1) | 1,000 | 36.00 | 227,530 | |||||||||
| 2024 Equity Incentive Plan (1) | – | – | 1,650,000 | |||||||||
| Total | 4,000 | 36.00 | 1,961,730 | |||||||||
(1) The weighted average exercise price relates to the options only. RSUs were excluded as they have no exercise price.
| 21 |
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
Related Party Transactions
The following is a summary of transactions since January 1, 2025 to which the Company was a participant in which the amount involved exceeded $120,000 and in which any director, executive officer, or beneficial owner of more than 5% of the Company’s common stock, or any immediate family member of the foregoing, had a direct or indirect material interest.
Termination and Settlement Agreement
On February 20, 2025, the Company and Yu-san “Debra” Chen Volpone, former Chief Executive Officer, entered into a Termination and Settlement Agreement, whereby the Company agreed to settle any amounts due under her employment agreement, dated January 1, 2025, for an aggregate $350,000 plus an additional reimbursement of $25,000 in legal expenses.
Divestment of Legacy Business
On December 30, 2025, the Company completed the divestment of its legacy business pursuant to a separation and distribution agreement. In connection with the transaction, equity interests associated with the divestment were distributed to certain former directors and officers of the Company.
Director Independence
The Board of Directors has determined that each of the Company’s current non-employee directors is independent within the meaning of the applicable Nasdaq Listing Rules.
| 22 |
STOCKHOLDER PROPOSALS TO BE PRESENTED AT THE NEXT ANNUAL MEETING
For a stockholder proposal to be considered for inclusion in our proxy statement for the 2027 annual meeting, the corporate secretary must receive the written proposal at our principal executive offices no later than the deadline stated below. Such proposals must comply with SEC regulations under Rule 14a-8 regarding the inclusion of stockholder proposals in company-sponsored proxy materials. Proposals should be addressed to:
Nixxy, Inc.
1178 Broadway, 3rd Floor
New York, NY 10001
Attention: Corporate Secretary
Under Rule 14a-8, to be timely, a stockholder’s notice must be received at our principal executive offices not less than 120 calendar days before the date of our proxy statement release to stockholders in connection with the previous year’s annual meeting. However, if we did not hold an annual meeting in the previous year or if the date of next year’s annual meeting has been changed by more than 30 days from the date of the previous year’s annual meeting, then the deadline is a reasonable time before we begin to print and send our proxy materials. Therefore, stockholder proposals intended to be presented at the 2027 annual meeting must be received by us at our principal executive office no later than 120 days prior to the anniversary date that proxy material for this year’s meeting were sent in order to be eligible for inclusion in our 2027 proxy statement and proxy relating to that meeting, which will be August 2, 2027. Any stockholder proposal, including any director nomination, submitted outside the processes of Rule 14a-8 under the Securities Exchange Act of 1934 for presentation at our 2027 annual meeting will be considered untimely for purposes of Rule 14a-4 and 14a-5 if notice thereof complying with Section 2.5 of our Bylaws is not received by our Corporate Secretary during the period beginning August 25, 2027 and ending September 24, 2027 (or, if the 2027 annual meeting is not held within 30 days of the anniversary of the Annual Meeting, by the tenth calendar day following the day on which public announcement of the date of the 2027 annual meeting is first made). Stockholders intending to solicit proxies in support of director nominees other than the Company’s nominees must also provide the notice required by Rule 14a-19 under the Securities Exchange Act of 1934 no later than September 24, 2027. Upon receipt of any proposal, we will determine whether to include such proposal in accordance with regulations governing the solicitation of proxies.
You may propose director candidates for consideration by the Board’s Corporate Governance and Nominating Committee. Any such recommendations should include the nominee’s name and qualifications for Board membership, information regarding the candidate as would be required to be included in a proxy statement filed pursuant to SEC regulations, and a written indication by the recommended candidate of her or his willingness to serve, and should be directed to the Corporate Secretary at our principal executive offices within the time period described above for proposals other than matters brought under SEC Rule 14a-8.
AVAILABILITY OF ANNUAL REPORT ON FORM 10-K
As required, we have filed our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “2025 10-K”) with the SEC. Stockholders may obtain, free of charge, a copy of the 2025 10-K by writing to us at 1178 Broadway, 3rd Floor, New York, NY 10001, Attention: Corporate Secretary, or from our website, https://investors.nixxy.com/.
| 23 |
STOCKHOLDERS SHARING THE SAME LAST NAME AND ADDRESS
The SEC has adopted rules that permit companies and intermediaries such as brokers to satisfy delivery requirements for proxy statements with respect to two or more stockholders sharing the same address by delivering a single proxy statement addressed to those stockholders. This process, which is commonly referred to as “householding,” potentially provides extra convenience for stockholders and cost savings for companies. We and some brokers household proxy materials, delivering a single proxy statement to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker or us that they are or we will be householding materials to your address, householding will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in householding and would prefer to receive a separate proxy statement, or if you currently receive multiple proxy statements and would prefer to participate in householding, please notify your broker if your shares are held in a brokerage account or us if you hold registered shares. You can notify us by sending a written request to 1178 Broadway, 3rd Floor, New York, NY 10001, Attention: Corporate Secretary.
WHERE YOU CAN FIND MORE INFORMATION
We file annual, quarterly and current reports, proxy statements and other information with the SEC. Such filings are made available on our Internet website, www.nixxy.com, as soon as reasonably practicable after they are filed with, or furnished to, the SEC. The information on our website is not, and shall not be deemed to be, a part of this Proxy Statement or incorporated into any other filings we make with the SEC. The SEC maintains an Internet site, www.sec.gov, which contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC, including the Company.
By Order of the Board of Directors,
| /s/ David Kratochvil | ||
| Name: | David Kratochvil | |
| Title: | Chairman |
November 18, 2026
| 24 |
APPENDIX A
FIRST AMENDMENT TO THE
NIXXY, INC.
2025 EQUITY INCENTIVE PLAN
Effective as of December 23, 2026, Nixxy, Inc., a Nevada corporation (the “Company”), established, and the stockholders approved, the first amendment (the “First Amendment”) to the Nixxy, Inc. 2025 Equity Incentive Plan (the “Plan”). Upon the effectiveness of the Company’s one-for-twenty (1:20) reverse stock split of its Common Stock at 12:01 a.m. Eastern Time on November 20, 2026 (the “Reverse Stock Split”), the number of shares of Common Stock reserved for issuance under the Plan was proportionately adjusted from 2,500,000 shares to 125,000 shares pursuant to Section 14 of the Plan. By adoption of this instrument, the Company now desires to amend the Plan to increase the maximum number of shares of Common Stock available for issuance under the Plan by 125,000 shares, from 125,000 shares to 250,000 shares, in each case on a post-Reverse Stock Split basis. Capitalized terms used but not defined herein have the meanings given to them in the Plan.
1.This First Amendment shall be effective as of the date it is approved by the Company’s stockholders at the Company’s 2026 Annual Meeting of Stockholders and shall be void in the absence of such approval.
2.The second sentence of Section 4 of the Plan is hereby amended and restated in its entirety to read as follows:
“The aggregate number of shares of Common Stock which may be issued pursuant to the Plan, subject to adjustment as provided in Section 14, is the sum of (i) 250,000 plus (ii) an annual increase on the first day of each calendar year beginning January 1, 2027 and ending on and including January 1, 2035 equal to the lesser of (A) five percent (5%) of the shares of Common Stock outstanding on the final day of the immediately preceding calendar year, and (B) such smaller number of shares of Common Stock as determined by the Board.”
3. This First Amendment shall only amend the provisions of the Plan referred to above, and those provisions not amended hereby shall be considered in full force and effect, unless the context indicates otherwise.
IN WITNESS WHEREOF, the Company has caused this First Amendment to be signed by David Kratochvil, a duly authorized officer of the Company, on [●], 2026.
| Dated: [●], 2026 | /s/ David Kratochvil | |
| David Kratochvil | ||
| Chairman | ||
| 25 |